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Essay
The sum of the parts
Graeme Mitchison
Thirty years ago, Francis Crick, in
his brilliant and combative little
book Of Molecules and Men (Seattle:
University of Washington; 1966),
expounded what could be regarded
as the biological reductionist’s credo.
The ultimate aim of a modern
biologist, he said, should be to
explain all biology in terms of
physics and chemistry; in particular,
it should be possible to explain the
development of organisms and the
function of higher nervous systems
in these terms. The book was
combative because he had an enemy
to deal with: the organicists and
vitalists who were plentiful in those
days. It’s probably fair to say that the
battle against vitalism has been won,
at any rate until another dark age
engulfs us. But there are other forms
of dissension from the outlook he
expressed, and one of the aims of a
recent CIBA Foundation Symposium
— The Limits of Reductionism in
Biology (London, 13–15 May 1997)
— was to explore these.
Those gathered at the meeting
ranged from ardent pro-reductionists
— our chairman Lewis Wolpert
(University College London) being a
distinguished example — to those
with a large anti-reductionist axe to
grind. In between were persons of
less determinate disposition, many of
them perhaps not even sure how
reductionism should be defined.
Fortunately, there was no shortage of
definitions; by the end of the
meeting, as many had been offered
as there were bodies in the room, or
perhaps rather more.
William Quinn, a physiologist
who studies memory at the
Massachusetts Institute of
Technology, suggested that anyone
who worked with a simplified model
system and believed that Nature was
simple at heart was a reductionist.
What he meant by simplification here
was not entirely obvious: “Pavlov
reduced dogs,” he said, meaning that
Pavlov treated his animals as
stimulus–response machines, ignoring
the fixations they developed towards
pieces of experimental apparatus.
From a common-sense standpoint,
reductionism means taking things
apart in order to understand how they
work. The ‘understanding’ aspect
needs to be emphasized, as it is a
frequent jibe against reductionism
that it consists only in taking apart
without any attempt at synthesis.
Both components are needed. As
Crick put it in Of Molecules and Men:
“it would be difficult to deduce the
detailed functions of a watch either
from the intact, unopened running
watch, or from the smashed pieces,
but a combination of these two
approaches would tell us most things
about the mechanism.”
It is, nevertheless, not entirely
clear how much synthesis or
integration is permitted before the
subject moves into a realm beyond
reductionism. Is statistical
thermodynamics a reductionist
subject? It has its reduced entities,
namely particles, but a property like
temperature — as the chemist Bob
Williams (University of Oxford)
repeatedly reminded us — is an
ensemble property, not deducible
from a single particle. Biological
theory at present seems in no danger
of losing sight of its constituents in
this way, but a certain degree of
abstraction is needed to grasp the
behaviour of complicated systems.
For example, Denis Noble
(University of Oxford) has for many
years studied the physiology of heart
muscle cells in an incontestably
reductionist mode, but is currently
attempting to integrate the
information he has obtained and
model a region of the intact heart.
His spectacular computer simulations
yield insights not attainable by
studying the individual components.
“Am I a reductionist?” he asked,
evidently anticipating a negative
response. “I’ve not a shadow of doubt
you are,” replied Wolpert.
Having failed to achieve
unanimity on this matter of
synthesis, we went on to do the same
with levels of organization. No one
thinks that it is sensible to try to
reduce an organism to atoms; instead,
one hopes to study it at several
levels, each reducible to the
preceding one. Take a frog snapping
at a fly: one can analyse the synaptic
pathway from retina to muscles, the
molecular components of synapses
can be teased apart, and the
structures of these components can
carry us to the level of atoms. But
one would not try to put the whole
structure together atom by atom.
Are there levels which are in
some sense not attainable from those
below? This would certainly
constitute a limit on reductionism.
From time to time, members of our
group would deliver jobations about
the impossibility of bringing
reductionism to bear on the issue of
purpose (such as, why the frog snaps
at the fly), and these would be
received with acquiescence. It’s not
clear, however, that this type of
limitation pertains particularly to
reductionism. Purpose carries us into
questions of evolution, and evolution
is part science and part history.
While these matters were being
debated, Robert May (University of
Oxford, and UK Government Chief
Scientist) dropped in from the
corridors of power to tell us about
population biology. Muttering “I
don’t know what I’m doing here,” he
told us, not without a touch of
impatience, that one should work at
whatever level was practical, and
reduce as far as was possible. This
sound advice leads one to speculate
about the future of reductionism.
What is practical, what is possible?
Will we really be able to put together
all the pieces being so energetically
produced by the great laboratory-
factories of the world?
The scientific world seems to
divide into those who think that
tasks which are too difficult for the
present, like modelling large-scale
cellular dynamics or folding proteins,
must always be unachievable, and
those who see it as only a matter of
time before they become routine.
History suggests it is safer to side
with the latter view: heavier-than-air
flying machines seem to be doing
quite well nowadays, there are
photographs of atoms in the journals
every week, and so on. It was good,
though, to have some dissent
throughout the meeting. Judged by
the criterion of liveliness, this was a
four-star meeting.
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Widespread eukaryotic
sequences, highly
similar to bacterial
DNA polymerase I,
looking for functions
Erik L.L. Sonnhammer
and John C. Wootton
The sequence databases now contain
several particularly interesting DNA
polymerase sequences for which
functions have not yet been
assigned. These sequences are
present and transcribed in
widespread eukaryotes. They are
strongly similar in their polymerase
domains to the familiar DNA
polymerase I (PolA family) of the
bacterial kingdom, and are only
weakly similar to Pol-γ, the enzyme
responsible for mitochondrial DNA
replication. Two distinct human
sequences are so far available: first, a
cDNA of a class that is also
represented by Caenorhabditis elegans
(nematode) genomic and cDNA
sequences; second, an intriguing set
of rather cryptic short exon
sequences interspersed in the 4p16.3
(Huntington’s disease) region [1] of
the genome. Partial cDNAs,
encoding parts of similar DNA
polymerase domains, are also
available from maize, Zea mays, and
the malarial parasite Plasmodium
falciparum. Similar sequences are
notably absent, however, from the
complete genome sequence of the
yeast Saccharomyces cerevisiae.
Different classes of DNA-
dependent DNA polymerases (EC
2.7.7.7) have well-established roles in
DNA replication, repair, mutagenesis
and recombination, and share
structural similarity in their
polymerase domains. The new
sequences analysed here clearly
belong to family A, as classified by
polymerase domain sequence
homology [2,3]. Family A
polymerases have functions in: DNA
repair, and RNA primer removal
during lagging strand replication in
bacteria (the PolA enzymes); DNA
replication in eukaryotic
mitochondria (the nuclear-encoded
Pol-γ group); and viral DNA
replication in several bacteriophages
[4,5]. All of these have 3′→5′ and/or
5′→3′ exonuclease domains on the
amino-terminal side of the
polymerase domain (Fig.1).
The most complete example of
the new polymerase sequences is a
conceptual translation from the C.
elegans genome (coding region
W03A3.2, Genbank U50184). This
contains, in addition to the
carboxy-terminal polymerase domain,
a long amino-terminal region that
does not contain any recognizable
sequence similarity to known
exonucleases. Six independent cDNA
clones are also available from
C. elegans, covering both the amino-
terminal and polymerase regions. No
expressed sequence tags (ESTs) from
other organisms match the amino-
terminal region. The two human
genes of this family are distantly
related to each other. One is a partial
cDNA (dbEST accession W00829),
and is more similar in sequence to the
C. elegans homolog than to the other
human gene. The second human
gene has been partially assembled
conceptually by sequence similarity
from 13 short exons interspersed over
approximately 130 kilobases of a
2 megabase contig from the
Huntington’s disease region of 4p16.3. 
Figure 2 shows the multiple
alignment of these sequences and
other DNA polymerase family A
representatives, including the new Z.
mays and P. falciparum partial cDNAs.
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Figure 1
The DNA polymerase domain in family A
occurs in combination with various other
domains. DNA polymerase domains are
colored blue, 3′→5′ exonuclease domains
orange, and 5′→3′ exonuclease domains are
green. In Thermus, an inactive ‘remnant’ of
the 3′→5′ exonuclease domain is present
[12] (dotted box). Swissprot accessions:
E. coli PolA: P00582; Human Pol-γ:
P54098; Thermus aquaticus PolA: P19821;
Bacteriophage T5: P19822. The amino-
terminal portion of W03A3.2 lacks clear
similarity to other sequences and contains
two low-complexity regions (pink circles),
which potentially divide it into three globular
subdomains.
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All these sequences contain the
characteristic conserved residue
patterns found in active DNA
polymerase domains [6], and show a
much greater similarity to PolA than
does Pol-γ. Phylogenetic analysis
indicates that both C. elegans W03A3.2
and the human 4p16.3 sequences are
placed among the deeper branches of
the PolA and bacteriophage
sequences (not shown). Pairwise
alignments using these eukaryotic
sequences show only very remote
homology to the mitochondrial Pol-γ
group. The question of the
evolutionary origins of these
apparently ancient DNA polymerase
lineages is completely open.
Recent bacterial contamination or
recent transfers from bacterial or
bacteriophage sources is evidently
ruled out by the presence of these
genes in diverse eukaryotes and by
their characteristic exon–intron
genomic structures. Also, analysis by
the Zinfo program [7] showed that
the compositional statistics of the
W03A3.2 coding sequence are typical
for C. elegans but atypical for E. coli.
The phylogeny and distribution,
including the occurrence of at least
two distantly related human paralogs,
could be consistent with multiple
ancient parallel transfer events as
well as with a single ancient transfer,
perhaps through the mitochondrial
line, followed by more recent gene
duplications. Some lineages,
including Pol-γ, may have undergone
phases of rapid evolution, together
with loss of exonuclease domains and
gain of other domains. Presumably,
given the wide distribution in protist,
plant and metazoan organisms, loss
of these polymerase genes occurred
in the ancestry of S. cerevisiae.
What are the possible functions
of these DNA polymerases?
Experimental verification of
polymerase activity is the next step,
but in the interim it is tempting to
consider DNA repair. It may be
pertinent to investigate the repair of
damage to mitochondrial DNA,
which is poorly understood but which
may have roles in the progression of
cancer, diabetes and other chronic
diseases [8–10]. A repair function is
also consistent with the absence of
these sequences in S. cerevisiae, as
there are well-established differences
in repair between this yeast and
mammalian cells [11].
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Figure 2
Alignment of the DNA polymerase domains
found in C. elegans W03A3.2, the human
4p16.3 gene, E. coli DNA polymerase I
(Swissprot: DPO1_ECOLI/P00582), S.
cerevisiae Pol-γ (Swissprot: DPOG_YEAST/
P15801) and ESTs from human, maize and
Plasmodium. The EST names indicate
Genbank accession numbers. The two dashed
segments in the 4p16.3 gene indicate exons
which are presumed necessary, but for which
no likely candidates were found based on
sequence similarity. X denotes uncertain exon
boundaries. The dash in T23354 indicates a
frameshift relative to the EST sequence. The
multiple alignment was constructed manually
based on BLAST2 [13] and TBLASTN [14]
alignments. The probability of observing the
similarity to PolA by chance, computed using
the BLASTP program [14], was <10–50 for
W03A3.2 and the 4p16.3 gene, and <10–6
for each of the EST translations, when
searched against the NCBI NR database. The
exon structure of W03A3.2 in Genbank was
altered according to EST evidence.
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Barth syndrome may
be due to an
acyltransferase
deficiency
Andrew F. Neuwald
Barth syndrome is an X-linked
inherited disorder characterized by
short stature, cardioskeletal
myopathy, neutropenia, abnormal
mitochondria, and respiratory-chain
dysfunction [1,2]. It is often fatal in
childhood due to cardiac failure or
sepsis arising from agranulocytosis.
The phenotype associated with this
disorder is quite variable, however,
and other X-linked cardiomyopathies
[3–5] may be allelic to Barth
syndrome, which maps to a gene-rich
region of Xq28 [6]. Recently, a gene
mutated in patients afflicted with
Barth syndrome (G4.5) was cloned
and sequenced [7]. It encodes
several proteins (designated
tafazzins) by means of alternate
splicing. The biological function of
tafazzins is unclear; a BLAST search
[8] finds significant pairwise
similarity only to two hypothetical
proteins: one from worm (g1130664),
and one from yeast (g1066481).
Here, I report that human
tafazzins belong to a superfamily
consisting of acyltransferases
involved in phospholipid
biosynthesis and other proteins of
unknown function. This superfamily
was found using PROBE [9], an
automated search and multiple
alignment program based on iterative
database searches. Starting with a
plant 1-acylglycerol-3-phosphate
acyltransferase (EC 2.3.1.51),
g1197334, PROBE returned a
superfamily that includes known and
putative acyltransferases from
bacteria, fungi, plants, and vertebrate
and invertebrate metazoans.
Characterized enzymes in this
superfamily all function in
phospholipid biosynthesis and have
either glycerolphosphate,
1-acylglycerolphosphate, or
2-acylglycerolphosphoethanolamine
acyltransferase activity.
The sequence alignment contains
five conserved regions that
presumably reflect similar structural
and functional features shared by
these proteins (Fig. 1). As all of the
characterized proteins are
acyltransferases involved in
phospholipid biosynthesis, the
uncharacterized proteins are likely to
have similar catalytic activity.
Notably, motif A contains a fully
conserved residue position that may
correspond to a catalytic histidine, as
has been found at the active site of
other CoA-dependent hydrolases
[10]. Of course, it is possible that
tafazzins perform some other
hydrolytic function. Indeed,
hydrolytic activity was previously
predicted for tafazzins based on
weak similarity to the Escherichia coli
radC gene [11], which may possess
hydrolytic activity needed for DNA
repair. Nevertheless, the more
extensive similarity of tafazzins to
these acyltransferases implies a
closer similarity in function.
The potential acyltransferase
activity of tafazzins suggests a
possible disease mechanism
underlying Barth syndrome.
Differential splicing of tafazzins [7]
and the existence of at least nine of
these putative acyltransferases in
roundworm — by contrast with the
four detected in the E. coli genome
— suggests that a variety of
substrate-specific or tissue- and
organelle-specific forms of these
acyltransferases exist in eukaryotes.
If so, then the mitochondrial
structural and respiratory-chain
abnormalities associated with Barth
syndrome may be due to alterations
in mitochondrial membrane
phospholipid composition.
Consistent with this notion, a
temperature-sensitive Chinese
hamster ovary cell mutant deficient
in an enzyme needed for cardiolipin
biosynthesis showed alterations in
mitochondrial morphology and
respiration [12]. 
It is important to note that the
roundworm ZK809.2 gene may be an
ortholog of the human G4.5
(tafazzins) gene. It shares several
splice sites with the human gene and
the predicted product is more closely
related to tafazzins than to any other
protein in the superfamily. Notably,
the worm protein is missing exon 5,
which appears to be removed from
many of the tafazzin splice variants
[7]. Furthermore, the worm homolog
shares several conserved regions with
human tafazzins that are
Magazine R465
unconserved in the superfamily as a
whole. Thus, ZK809.2 mutants may
serve as a useful model to explore
the molecular mechanisms
underlying Barth syndrome.
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Figure 1
protein startMotif A Motif B Motif C Motif D Motif E end description
g1263110 62 PLITVSNHQSCMDDPHLWGIL (16)AADICFTKELHSHFFSLGKCVPVCR (48)GDWVHIFPEGKV (8) FKWGIGRLI (19)VLPNSPPY 227 (65) tafazzin (human)
g1130664 37 PLITVSNHRSNIDDPLMWCIL (17)AHNICFTKQFHTTMFSLGRCVPCVR (18)NKWVHIFPEGKV (9) FKWGIGRLV (19)VWPTQPPY 174 (74) ZK809.2 (worm)
g1066481 70 GLMTVMNHMSMVDDPLVWATL (16)AHNICFQNKFLANFFSLGQVLSTER (49)PSWVHVYPEGFV (13) FKWGITRMI (40)EINVTIGD 262 (119) P9659.5 (yeast)
g1458274 218 PALIIMNHRTRLDWLFFWNAL (14)LKGMLKYVPGAGWAMQAASYIFLDR (21)KYQLLLFPEGTD (26) PRVTGFVHI (12)IYDVSIGF 365 (158) agpat (worm)
S52645 85 HALIISNHRSDIDWLIGWILA (12)MKKSSKFLPVIGWSMWFAEYLFLER (21)PFWLALFVEGTR (26) PRTKGFVSA (10)IYDTTVIV 228 (146) agpat (maize)
g1197334 102 RAIYISNHASPIDAFFVMWLA (7) AKKEVIWYPLLGQLYTLAHHIRIDR (20)NLSLIMFPEGTR (35) WRKGTFRVR (0) PVPITVKY 238 (43) agpat (vascular plant)
P33333 75 PYIMIANHQSTLDIFMLGRIF (7) AKKSLKYVPFLGWFMALSGTYFLDR (20)KRALWVFPEGTR (10) FKKGAFHLA (77)LPPQAIEY 263 (40) agpat (yeast)
P26647 66 NAIYIANHQNNYDMVTASNIV (7) GKKSLLWIPFFGQLYWLTGNLLIDR (20)RISIWMFPEGTR (8) FKTGAFHAA (6) IIPVCVST 181 (64) agpat (E. coli)
D64223 85 PVLVVANHKSNLDPLVLIKAF (11)VAKIELKDTVLFKLMKLIDCVFIDR (19)GTAIAVFAEGTR (8) FKPGALKVA (6) ILPVSIVG 203 (65) agpat (M. genitalium)
g972978 71 GVLVAANHVSWLDIFAMSAVY (5) AKQEIKSWPVLGKMGQNAGTVFINR (19)GQNVSFFPEART (10) FKAALFQSA (6) VLAVALRY 185 (72) agpat (N. meningitidis)
A41672 223 PLLFLPVHRSHIDYLLLTFIL (10)ASGNNLNIPVFSTLIHKLGGFFIRR (28)QQFLEIFLEGTR (0) SRSGKTSCA (21)VIPVGISY 356 (471) gpat (mouse)
g1458332 160 PMVYLPLHRSHLDYLLITWCN (10)ASGDNLNLSGLGWLLRATGAFFIRR (28)DMPIEFFLEGTR (8) PKNGLISNV (13)LVPVSYTY 293 (425) gpat (worm)
P30706 220 NIILMSNHQSEADPAIIALLL (38)SKKHMLDNPELVDMKRKANTRSRKE (8) SQIIWIAPSGGR (9) WAPAPFDSS (17)IYPLAILC 366 (91) PlsB (PEA)
P00482 319 ELVYVPCHRSHMDYLLLSYVL (10)AAGINLNFWPAGPIFRRLGAFFIRR (22)GYSVEYFVEGGR (8) PKTGTLSMT (13)LIPIYIGY 446 (381) PlsB (E. coli)
P31119 29 RVLITPNHVSFIDGILLGLFL (20)LKSFIDFVPLDPTQPMAIKHLVRLV (2) GRPVVIFPEGRI (8) IYDGAGFVA (6) VIPVRIEG 139 (580) agpeat (E.coli)
g1841552 89 PYVVVSNHQSSLDLLGMMEVL (7) AKRELLWAGSAGLACWLAGVIFIDR (20)DVRVWVFPEGTR (8) FKRGAFHLA (6) IVPIVMSS 204 (71) ORF (human)
g1503994 94 EAVMLVNHQATGDVCTLMMCL (12)LMDHIFKYTNFGIVSLVHGDFFIRQ (24)RKWIVLFPEGGF (25) PRSGATKII (30)IIDTTIAY 259 (111) KIAA0205 (human)
g1256468 97 RALLLPNHLGLFDHFIFMTAA (13)VIYNMWIYSPLGWLWSSYGNYFIDS (25)LRWLCLYPEGSR (25) PRLGAALSA (24)LVDVTLGY 258 (105) F08G5.2 (worm)
g1301695 42 PAMIVMNHRTRLDWMYMWCAL (14)LKAQLKKLPGAGFGMAAAQFVFLER (21)KYQILLFPEGTD (26) PRTTGFLHL (37)IYDITIAY 214 (225) F55A11.5 (worm)
g1403001 91 PAVVICNHQSSLDILSMASIW (7) MKRILAYVPFFNLGAYFSNTIFIDR (20)NLKLWVFPEGTR (8) FKKGAFNIA (6) IIPVVFSD 206 (76) T06E8.1 (worm)
g1673483 87 PYIIIANHQSALDVLGMSFAW (7) LKSSLKYLPGFNLCAYLCDSVYINR (20)KRKVWIYPEGTR (8) FKKGAFILA (6) IVPCVFSS 202 (3) F59F4.4 (worm)
g798827 237 GGICVANHTSPIDVMVLSCDN (20)SRSEHHIWFERGEAGDRAKVMDRMR (7) KLPIIIFPEGTC (8) FKKGSFEIG (2) IYPIAVKY 348 (164) R07E3.5 (worm)
g746580 117 KCLLLANHLGLLDHFVLMQSL (12)VIYNIWKYTPLGVMWTSHGNFFVNG (24)YGWVIMYPEGSR (25) PRTGAAHAV (24)IIDATIGY 276 (115) C01C10.3 (worm)
g1420660 149 TTLMICNHRSVNDYTLINYLF (29)LKFLGWGKMFNFPRLDLLKNIFFKD (18)NQAITIFPEVNI (29) FKNFTTLMA (79)IYDVTIIY 378 (101) YOR298w (yeast)
P38226 105 NSVAICNHQIYTDWIFLWWLA (12)LKKSLASIPILGFGMRNYNFIFMSR (54)PYNLILFPEGTN (4) TRQKSAKYA (32)LYDITIGY 281 (116) Ybp2p (yeast)
S54641 110 RAIIIANHQMYADWIYLWWLS (12)LKKALQYIPLLGFGMRNFKFIFLSR (41)AYNLIMFPEGTN (28) PHSKGLKFA (10)IYDVTIGY 275 (121) YD9335.04c (yeast)
g1653690 57 PALVVSNHASYFDPPFLSCAM (7) AKEELFNVPLLGPAIRLYGAYPVKR (17)GWLVGVFLEGTR (8) PKLGAAMIA (6) IIPVSLGG 169 (56) ORF (Synechocystis)
g1652948 64 RLLLAFRHPSINDPLCMGYLF (7) LKKGALQPPPVSHSHFMYDRGIPLW (37)QYPLAAAPEGAT (9) LEPGIAQLG (17)ILPVGIQY 208 (257) ORF (Synechocystis)
g1652152 54 PIILAPTHRSRWDAILLSLAA (3) VTGRDLRFMVAVTEVQGLQGWFIRH (25)GEMLVIFPEGGI (9) LKRGIGRIA (13)VIPVTIAY 178 (62) ORF (Synechocystis)
P32129 96 WYLLICNHRSWADIVVLCVLF (10)LKQQLAWVPFLGLACWSLDMPFMKR (30)PTTIVNFVEGSR (18) PKAAGIAMA (10)LLNVTLCY 238 (72) YihG (E. coli)
Q11167 143 AALVVANHAGVLPFDGLMLSV (15)AADMVFDLPVIGEAARKAGHTMACT (9) GELTAVFPEGYK (14) FGRGGFVSA (7) IVPCSIIG 262 (96) YV29 (M. tuberculosis)
Alignment of representative sequences in the
tafazzins, or acyltransferase superfamily. A
total of 53 proteins in the NCBI non-
redundant database were detected by the
PROBE search [9], which used default
parameter settings. Conserved residues are
highlighted in red (for the most conserved
positions) or black. Numbers in parentheses
are gap lengths. Human tafazzin is detected
at the p < 0.00001 level of significance; this
is based on a database search using an
alignment lacking sequences with statistically
significant pairwise similarity to tafazzins (that
is, lacking sequences g1263110,
g1130664, g1066481, g1841552,
g1403001 and g1673483). (The database
search and the p-value calculation were done
as previously described [13].) Protein
identifiers are highlighted according to the
following color scheme: black, tafazzin and
close homologs; red, 1-acylglycerol-
phosphate acyltransferases (agpat); blue,
glycerolphosphate acyltransferases (gpat);
green, 2-acylglycerolphosphoethanolamine
acyltransferase (agpeat); unhighlighted,
proteins of unknown function.
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